Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04417517
Title A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ALX Oncology Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Southern California, Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
IU Simon Cancer Center Indianapolis Indiana 46202 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Asan Medical Center Seoul Korea, Republic of Details
Samsung Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Seoul Saint Mary's Hospital Seoul Korea, Republic of Details
Severance Hospital Seoul Korea, Republic of Details
Hospital General Universitario de Alicante Alicante 03010 Spain Details
Hospital San Pedro de Alcantara Cáceres 10003 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitari i Politecnic La Fe de Valencia Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field